DK0512071T3 - Fremgangsmåde og sammensætninger til inhibering af angiogenese - Google Patents

Fremgangsmåde og sammensætninger til inhibering af angiogenese

Info

Publication number
DK0512071T3
DK0512071T3 DK91904851.2T DK91904851T DK0512071T3 DK 0512071 T3 DK0512071 T3 DK 0512071T3 DK 91904851 T DK91904851 T DK 91904851T DK 0512071 T3 DK0512071 T3 DK 0512071T3
Authority
DK
Denmark
Prior art keywords
collagenase
inhibitor
compositions
specific
methods
Prior art date
Application number
DK91904851.2T
Other languages
Danish (da)
English (en)
Inventor
Marsha A Moses
Judith Sudhalter
Original Assignee
Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital filed Critical Childrens Hospital
Application granted granted Critical
Publication of DK0512071T3 publication Critical patent/DK0512071T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK91904851.2T 1990-01-25 1991-01-25 Fremgangsmåde og sammensætninger til inhibering af angiogenese DK0512071T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47006790A 1990-01-25 1990-01-25
US59155990A 1990-10-02 1990-10-02

Publications (1)

Publication Number Publication Date
DK0512071T3 true DK0512071T3 (da) 1996-11-25

Family

ID=27042958

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91904851.2T DK0512071T3 (da) 1990-01-25 1991-01-25 Fremgangsmåde og sammensætninger til inhibering af angiogenese

Country Status (10)

Country Link
EP (1) EP0512071B1 (fr)
JP (1) JPH06509791A (fr)
AT (1) ATE144710T1 (fr)
AU (1) AU652744B2 (fr)
CA (1) CA2074725A1 (fr)
DE (1) DE69122956T2 (fr)
DK (1) DK0512071T3 (fr)
ES (1) ES2093699T3 (fr)
GR (1) GR3021925T3 (fr)
WO (1) WO1991011193A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268384A (en) * 1990-11-21 1993-12-07 Galardy Richard E Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
US5853746A (en) * 1991-01-31 1998-12-29 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
DE4106570A1 (de) * 1991-03-01 1992-09-03 Max Planck Gesellschaft Neue inhibitoren der endothelzell-proliferation
DE69435342D1 (de) * 1993-07-19 2011-05-05 Angiotech Pharm Inc Anti-Angiogene Mittel und Verfahren zu deren Verwendung
US20030203976A1 (en) 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
AU728873B2 (en) * 1993-07-19 2001-01-18 Angiotech Pharmaceuticals, Inc. Anti-angiogenic compositions and methods of use
AU771815B2 (en) * 1993-07-19 2004-04-01 Angiotech Pharmaceuticals, Inc. Anti-angiogenic compositions and methods of use
US5716981A (en) * 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
US6562596B1 (en) * 1993-10-06 2003-05-13 Amgen Inc. Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
US5837680A (en) * 1996-02-16 1998-11-17 Children's Medical Center Corporation Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US20040254635A1 (en) 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
US6120847A (en) * 1999-01-08 2000-09-19 Scimed Life Systems, Inc. Surface treatment method for stent coating
US6419692B1 (en) 1999-02-03 2002-07-16 Scimed Life Systems, Inc. Surface protection method for stents and balloon catheters for drug delivery
US6156373A (en) 1999-05-03 2000-12-05 Scimed Life Systems, Inc. Medical device coating methods and devices
ES2243556T3 (es) 2000-10-16 2005-12-01 Conor Medsystems, Inc. Dispositivo medico expandible para proporcionar un agente beneficioso.
US20040073294A1 (en) 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
EP1545588A4 (fr) * 2002-07-23 2007-12-05 Ludwig Inst Cancer Res Procedes et compositions pour l'activation ou l'inhibition du facteur de croissance endothelial vasculaire d et du facteur de croissance endothelial vasculaire c
WO2004087214A1 (fr) 2003-03-28 2004-10-14 Conor Medsystems, Inc. Dispositif medical implantable a gradient de concentration d'agent utile
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
KR101539700B1 (ko) * 2012-09-05 2015-07-28 아주대학교산학협력단 연골세포 유래 세포외 기질막을 이용한 신생혈관질환 치료용 조성물 및 각막 또는 결막 이식재
WO2014038866A1 (fr) * 2012-09-05 2014-03-13 아주대학교산학협력단 Composition pour traitement des maladies angiogéniques à l'aide d'une membrane de matrice extracellulaire de cellules dérivées de cartilage, et matériel pour greffe de cornée ou de conjonctive

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4766111A (en) * 1985-10-31 1988-08-23 Trustees Of Boston University Lipids with plasmin inhibitory properties
US5260059A (en) * 1989-04-14 1993-11-09 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor

Also Published As

Publication number Publication date
GR3021925T3 (en) 1997-03-31
ES2093699T3 (es) 1997-01-01
AU7335191A (en) 1991-08-21
EP0512071A4 (en) 1993-05-05
EP0512071B1 (fr) 1996-10-30
ATE144710T1 (de) 1996-11-15
JPH06509791A (ja) 1994-11-02
DE69122956T2 (de) 1997-05-22
WO1991011193A1 (fr) 1991-08-08
DE69122956D1 (de) 1996-12-05
CA2074725A1 (fr) 1991-07-26
EP0512071A1 (fr) 1992-11-11
AU652744B2 (en) 1994-09-08

Similar Documents

Publication Publication Date Title
DK0512071T3 (da) Fremgangsmåde og sammensætninger til inhibering af angiogenese
DE69826847D1 (de) Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose
DE60037726D1 (de) Carbonsäurederivate die die bindung von integrinen an ihre rezeptoren hemmen
TR200102648T2 (tr) Büyümeyi destekleyen bileşimler
UA40578C2 (uk) Сульфоніламінопіримідини і фармацевтичний препарат на їх основі
NO20005162D0 (no) Forbindelser som inhiberer bindingen av integriner til deres reseptorer
NO991100L (no) Assosiasjon av NO-syntaseinhibitorer med feller for reaktive oksygenformer
DK1203766T3 (da) Carboxylisyrederivater, der hæmmer bindingen af integriner til deres receptorer
DE122011100032I1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer.
DE60014369D1 (de) Propansäurederivate, die die bindung von integrinen an ihre rezeptoren behindern
DK0844874T3 (da) Fremgangsmåder og sammensætninger egnet til inhibering af alfa v beta 5-medieret angiogenese
DE60136618D1 (de) Verwendung von 13-hode als regulator der vaskulären biokompatibilität und als inhibitor der zellulären hyperplasie
DK0817646T3 (da) Fremgangsmåder til behandling af inflammation og præparater derfor
ATE240100T1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
DK0644768T3 (da) Fremgangsmåder og præparater til inhibering af endotelcelle- og fibrinogenfremkaldt inflammation
ATE329613T1 (de) Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas